These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34917780)

  • 1. Combining inter-observer variability, range and setup uncertainty in a variance-based sensitivity analysis for proton therapy.
    Hofmaier J; Walter F; Hadi I; Rottler M; von Bestenbostel R; Dedes G; Parodi K; Niyazi M; Belka C; Kamp F
    Phys Imaging Radiat Oncol; 2021 Oct; 20():117-120. PubMed ID: 34917780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of treatment optimization directly incorporating random patient setup uncertainty with a margin-based approach.
    Moore JA; Gordon JJ; Anscher MS; Siebers JV
    Med Phys; 2009 Sep; 36(9):3880-90. PubMed ID: 19810460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variance-based sensitivity analysis for uncertainties in proton therapy: A framework to assess the effect of simultaneous uncertainties in range, positioning, and RBE model predictions on RBE-weighted dose distributions.
    Hofmaier J; Dedes G; Carlson DJ; Parodi K; Belka C; Kamp F
    Med Phys; 2021 Feb; 48(2):805-818. PubMed ID: 33210739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer.
    Shan J; Yang Y; Schild SE; Daniels TB; Wong WW; Fatyga M; Bues M; Sio TT; Liu W
    Med Phys; 2020 Nov; 47(11):5428-5440. PubMed ID: 32964474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter-observer variability in target delineation increases during adaptive treatment of head-and-neck and lung cancer.
    Apolle R; Appold S; Bijl HP; Blanchard P; Bussink J; Faivre-Finn C; Khalifa J; Laprie A; Lievens Y; Madani I; Ruffier A; de Ruysscher D; van Elmpt W; Troost EGC
    Acta Oncol; 2019 Oct; 58(10):1378-1385. PubMed ID: 31271079
    [No Abstract]   [Full Text] [Related]  

  • 6. A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties.
    Park PC; Zhu XR; Lee AK; Sahoo N; Melancon AD; Zhang L; Dong L
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e329-36. PubMed ID: 21703781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers.
    Liu W; Frank SJ; Li X; Li Y; Park PC; Dong L; Ronald Zhu X; Mohan R
    Med Phys; 2013 May; 40(5):051711. PubMed ID: 23635259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
    Stützer K; Lin A; Kirk M; Lin L
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The energy margin strategy for reducing dose variation due to setup uncertainty in intensity modulated proton therapy (IMPT) delivered with distal edge tracking (DET).
    Zhang M; Flynn RT; Mo X; Mackie TR
    J Appl Clin Med Phys; 2012 Sep; 13(5):3863. PubMed ID: 22955652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head and neck IMPT probabilistic dose accumulation: Feasibility of a 2 mm setup uncertainty setting.
    Wagenaar D; Kierkels RGJ; van der Schaaf A; Meijers A; Scandurra D; Sijtsema NM; Korevaar EW; Steenbakkers RJHM; Knopf AC; Langendijk JA; Both S
    Radiother Oncol; 2021 Jan; 154():45-52. PubMed ID: 32898561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous
    Maclean J; Fersht N; Sullivan K; Kayani I; Bomanji J; Dickson J; O'Meara C; Short S
    Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):448-458. PubMed ID: 28433399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical assessment of proton treatment plans under setup and range uncertainties.
    Park PC; Cheung JP; Zhu XR; Lee AK; Sahoo N; Tucker SL; Liu W; Li H; Mohan R; Court LE; Dong L
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):1007-13. PubMed ID: 23688812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of interventions to reduce inter-observer variability in volume delineation in radiation oncology.
    Vinod SK; Min M; Jameson MG; Holloway LC
    J Med Imaging Radiat Oncol; 2016 Jun; 60(3):393-406. PubMed ID: 27170216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.
    Liu W; Schild SE; Chang JY; Liao Z; Chang YH; Wen Z; Shen J; Stoker JB; Ding X; Hu Y; Sahoo N; Herman MG; Vargas C; Keole S; Wong W; Bues M
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):523-533. PubMed ID: 26725727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of high dose volumetric CT on PTV margin reduction in VMAT prostate radiotherapy.
    Cho YB; Alasti H; Kong V; Catton C; Berlin A; Chung P; Bayley A; Jaffray D
    Phys Med Biol; 2019 Mar; 64(6):065017. PubMed ID: 30731450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target volume dose considerations in proton beam treatment planning for lung tumors.
    Engelsman M; Kooy HM
    Med Phys; 2005 Dec; 32(12):3549-57. PubMed ID: 16475753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of range uncertainty on clinical distributions of linear energy transfer and biological effectiveness in proton therapy.
    Hahn C; Eulitz J; Peters N; Wohlfahrt P; Enghardt W; Richter C; Lühr A
    Med Phys; 2020 Dec; 47(12):6151-6162. PubMed ID: 33118161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric consequences of image guidance techniques on robust optimized intensity-modulated proton therapy for treatment of breast Cancer.
    Liang X; Mailhot Vega RB; Li Z; Zheng D; Mendenhall N; Bradley JA
    Radiat Oncol; 2020 Feb; 15(1):47. PubMed ID: 32103762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets.
    Thörnqvist S; Muren LP; Bentzen L; Hysing LB; Høyer M; Grau C; Petersen JB
    Acta Oncol; 2013 Apr; 52(3):521-7. PubMed ID: 23409771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric impact of range uncertainty in passive scattering proton therapy.
    Liu R; Sun B; Zhang T; Williamson JF; O'Sullivan JA; Zhao T
    J Appl Clin Med Phys; 2021 May; 22(5):6-14. PubMed ID: 33797840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.